In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen Endpoints News Indivior loses patent battle for Suboxone Film BioPharma Dive Indivior shares hit by suboxone patent ruling MarketWatch Full coverage